jRCT1030240137招募中不适用
Elucidation of the kinetics and mechanism of action of EPHB4-CAR-T cells in the human body:Phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors with expression of EPHB4 receptor (Elucidation of the kinetics and mechanism of action of EPHB4-CAR-T cells in the human body:Phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors with expression of EPHB4 receptor)
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 18
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •1.Patients enrolled in CARTiEr study
- •2.Written consent has been obtained from the patient for this ancillary study.
排除标准
- •1.Written consent has not been obtained from the patient for this ancillary study.
- •2.Patients who are regarded as inappropriate for enrollment by investigators.
结局指标
主要结局
-
Incidence of Secondary Cancer Incidence of delayed toxicity
次要结局
- Overall survival
研究者
相似试验
尚未招募
不适用
Translational research on a prospective observational study of atezolizumab in patients with triple-negative breast cancer (JBCRG-C08)Triple-negative Breast cancerJPRN-UMIN000045279Cancer Institute Hospital of JFCR Breast Oncology Center40
已完成
不适用
Translational research to study the effect and mechanism of microbiota in paediatric immune-mediated diseases.immune-mediated diseases / disturbed immune system diseases10027665NL-OMON30483niversitair Medisch Centrum Utrecht60
招募中
不适用
Clinical translational and epidemiological research project on SARS coronavirus 2 infection in during the COVID 19 pandemic children in BavariaU07.1COVID-19, virus identifiedDRKS00022380Dr. von Haunersches KinderspitalLMU Klinikum14,000
招募中
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C (CODEBREAK)locally-advanced and unresectable or metastatic NSCLC with KRAS G12CMedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 25.1Level: LLTClassification code: 10069759Term: KRAS mutation Class: 10018065CTIS2024-510837-16-00Institut Gustave Roussy40
进行中（未招募）
1 期
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic non-small-cell lung cancerocally-advanced and unresectable or metastatic non-small-cell lung cancer with KRAS G12C mutationEUCTR2021-006958-31-FRGustave Roussy40